Tourmaline Bio Inc. (TRML) — Long-term Investment Intensity
Tourmaline Bio Inc. (TRML) has a Long-term Investment Intensity of 6.4% as of June 2025. Long-term investments of $17.18 Million represent 6.4% of total assets of $269.30 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of Tourmaline Bio Inc. for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Tourmaline Bio Inc. Long-term Investment Intensity (2024–2024)
This chart shows how Tourmaline Bio Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of June 2025, the intensity stands at 6.4%, reflecting long-term investments of $17.18 Million against total assets of $269.30 Million USD. Also explore TRML current and non-current assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Tourmaline Bio Inc. (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for Tourmaline Bio Inc. from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see TRML market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 11.9% | $36.63 Million | $309.00 Million | — |